Hoth Therapeutics, Inc. Common Stock
Symbol: HOTH (NASDAQ)
Company Description:
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).
- Today's Open: $1.67
- Today's High: $1.906
- Today's Low: $1.51
- Today's Volume: 2.79M
- Yesterday Close: $1.6
- Yesterday High: $1.8
- Yesterday Low: $1.59
- Yesterday Volume: 1.87M
- Last Min Volume: 400
- Last Min High: $1.61
- Last Min Low: $1.61
- Last Min VWAP: $1.61
- Name: Hoth Therapeutics, Inc. Common Stock
- Website: https://www.hoththerapeutics.com
- Listed Date: 2019-02-15
- Location: NEW YORK, NY
- Market Status: Active
- CIK Number: 0001711786
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $21.21M
- Round Lot: 100
- Outstanding Shares: 13.26M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-09-12 | 8-K | View |
2025-08-28 | 4 | View |
2025-08-22 | 8-K | View |
2025-08-12 | 10-Q | View |
2025-08-05 | S-8 | View |
2025-08-05 | 8-K | View |
2025-06-24 | 8-K | View |
2025-06-20 | 8-K | View |
2025-06-16 | ARS | View |
2025-06-16 | DEFA14A | View |
2025-06-16 | DEF 14A | View |
2025-06-09 | 8-K | View |
2025-05-21 | 3 | View |
2025-05-16 | 8-K | View |
2025-05-12 | 10-Q | View |
2025-05-02 | 8-K | View |
2025-04-15 | 8-K | View |
2025-03-28 | 10-K | View |
2025-03-25 | 8-K | View |
2025-02-07 | 8-K | View |